FindTrial
Sign In

Creatine intake in hemodialysis patients

Evaluation of creatine supplementation in renal hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-55vv9b2
Enrollment
Unknown
Registered
2022-08-18
Start date
2019-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Creatine Group: 14 individuals over 18 years of age with chronic kidney disease on hemodialysis will receive supplementation of 5 grams of creatine plus 5g of maltodextrin for 12 months and evaluated
G07.203.300.456

Sponsors

Faculdade de Medicina
Lead Sponsor
Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: chronic kidney disease; both genders; age between 18 to 60 years; hemodialysis treatment

Exclusion criteria

Exclusion criteria: Diagnosis of impaired cognitive function; communication difficulties; hearing deficiency; amputations

Design outcomes

Primary

MeasureTime frame
Attenuation in muscle mass loss assessed by bioimpedance—

Secondary

MeasureTime frame
0.5 kg increase in free fat mass in patients supplemented with creatine—

Countries

Brazil

Contacts

Public ContactGustavo Pimentel

Universidade Federal de Goiás

gupimentel@yahoo.com.br+55-62-996300080

Outcome results

None listed

Source: REBEC (via WHO ICTRP)